CD40 and chronic kidney disease: In vitro, exposure to either CKD serum (plasma Hcy level: 20.3 μmol/L) or Hcy (100 μmol/L) induced the differentiation of PBMCs into CD40+ and CD40+ intermediate subtypes [102].